KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Cash (2016 - 2025)

Historic Change in Cash for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $134.0 million.

  • Bio-Rad Laboratories' Change in Cash rose 7268.04% to $134.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $42.4 million, marking a year-over-year decrease of 5035.13%. This contributed to the annual value of $42.4 million for FY2025, which is 5035.13% down from last year.
  • Bio-Rad Laboratories' Change in Cash amounted to $134.0 million in Q4 2025, which was up 7268.04% from $26.5 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Change in Cash ranged from a high of $331.5 million in Q1 2022 and a low of -$393.4 million during Q4 2021
  • Over the past 5 years, Bio-Rad Laboratories' median Change in Cash value was $18.5 million (recorded in 2021), while the average stood at -$6.7 million.
  • Per our database at Business Quant, Bio-Rad Laboratories' Change in Cash surged by 303082.44% in 2022 and then tumbled by 48007.66% in 2025.
  • Bio-Rad Laboratories' Change in Cash (Quarter) stood at -$393.4 million in 2021, then surged by 78.72% to -$83.7 million in 2022, then surged by 35.65% to -$53.9 million in 2023, then surged by 244.05% to $77.6 million in 2024, then surged by 72.68% to $134.0 million in 2025.
  • Its Change in Cash was $134.0 million in Q4 2025, compared to $26.5 million in Q3 2025 and -$151.4 million in Q2 2025.